1.0Creatiohttps://www.ub.edu/creatiocreatio-adminhttps://www.ub.edu/creatio/author/creatio-admin/rich600338<blockquote class="wp-embedded-content" data-secret="PtsyLa3665"><a href="https://www.ub.edu/creatio/en/news/utox-acquisition/">UTOX acquisition (Preclinical Studies)</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.ub.edu/creatio/en/news/utox-acquisition/embed/#?secret=PtsyLa3665" width="600" height="338" title="«UTOX acquisition (Preclinical Studies)» — Creatio" data-secret="PtsyLa3665" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.ub.edu/creatio/wp-includes/js/wp-embed.min.js </script> https://www.ub.edu/creatio/wp-content/uploads/2023/06/Noticia-UTOX_Foto-lab_baixa-scaled.jpg20481365Creatio, a production and validation centre of advanced therapies of the University of Barcelona, through the Bosch i Gimpera Foundation, has acquired UTOX, the experimental toxicology platform of the Barcelona Science Park (PCB). The aim of this acquisition is for UTOX to integrate into the technology development centre, Creatio, leader in advanced therapies and member […]